OCR
Pre-clinic drug testing
Image
Dominique Tierny
Founder
OCR is a Contract Research Organization (CRO) offering pharmas & biotechs to test their drugs under developement on canine models either before moving to man or getting market approval for animal medication.
The fact is that dogs' cell growth is much quicker than humans'. And since dogs can develop the same type of illness than humans (example: cancers), OCR decided to build an infrastructure that both helps cure the dogs and foster science.
OCR has a top level multidisciplinary team driven by high ethical and Scientific standards.
OCR is base near Lille, Northern France.
The company was acquired by Cling Global in 2024.